The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000162.5(GCK):c.1279_1358delinsTTACA (p.Val427_Ser453delinsLeuGln)

CA213742

36190 (ClinVar)

Gene: GCK
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 43aa0893-88c7-4f72-bde3-6b90a3389316
Approved on: 2023-12-02
Published on: 2023-12-02

HGVS expressions

NM_000162.5:c.1279_1358delinsTTACA
NM_000162.5(GCK):c.1279_1358delinsTTACA (p.Val427_Ser453delinsLeuGln)
NC_000007.14:g.44145176_44145255delinsTGTAA
CM000669.2:g.44145176_44145255delinsTGTAA
NC_000007.13:g.44184775_44184854delinsTGTAA
CM000669.1:g.44184775_44184854delinsTGTAA
NC_000007.12:g.44151300_44151379delinsTGTAA
NG_008847.1:g.49169_49248delinsTTACA
NG_008847.2:g.57916_57995delinsTTACA
ENST00000395796.8:c.*1277_*1356delinsTTACA
ENST00000616242.5:c.*399_*478delinsTTACA
ENST00000683378.1:n.505_584delinsTTACA
ENST00000336642.9:c.313_392delinsTTACA
ENST00000345378.7:c.1282_1361delinsTTACA
ENST00000403799.8:c.1279_1358delinsTTACA
ENST00000671824.1:c.1342_1421delinsTTACA
ENST00000672743.1:n.291_370delinsTTACA
ENST00000673284.1:c.1279_1358delinsTTACA
ENST00000336642.8:c.331_410delinsTTACA
ENST00000345378.6:c.1282_1361delinsTTACA
ENST00000395796.7:c.1276_1355delinsTTACA
ENST00000403799.7:c.1279_1358delinsTTACA
ENST00000437084.1:c.1228_1307delinsTTACA
ENST00000459642.1:n.659_738delinsTTACA
ENST00000616242.4:c.1276_1355delinsTTACA
NM_000162.3:c.1279_1358delinsTTACA
NM_033507.1:c.1282_1361delinsTTACA
NM_033508.1:c.1276_1355delinsTTACA
NM_000162.4:c.1279_1358delinsTTACA
NM_001354800.1:c.1279_1358delinsTTACA
NM_001354801.1:c.268_347delinsTTACA
NM_001354802.1:c.139_218delinsTTACA
NM_001354803.1:c.313_392delinsTTACA
NM_033507.2:c.1282_1361delinsTTACA
NM_033508.2:c.1276_1355delinsTTACA
NM_033507.3:c.1282_1361delinsTTACA
NM_033508.3:c.1276_1355delinsTTACA
NM_001354803.2:c.313_392delinsTTACA

Uncertain Significance

Met criteria codes 3
PM4 PP4 PM2_Supporting
Not Met criteria codes 2
PS4 PM1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 1.2.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.1279_1358delinsTTACA variant in the glucokinase gene, GCK, is an 80 base pair deletion/ 5 base pair insertion resulting in the in-frame deletion of 27 amino acid(s) and insertion of 2 novel amino acids between codons 427 and 453 (p.(Val427_Ser453delinsLeuGln)) within exon 10 of NM_000162.5. The c.1279_1358delinsTTACA variant is predicted to change the length of the protein due an in-frame deletion of 27 amino acids and insertion of 2 novel amino acids for a net loss of 25 amino acids in a nonrepeat region (PM4). This variant was identified in three unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 28726111, internal lab contributors). One of these individuals had a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; PMID:28726111). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, c.1279_1358delinsTTACA meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PM4, PP4, PM2_Supporting.
Met criteria codes
PM4
The c.1279_1358delinsTTACA variant is predicted to change the length of the protein due an in-frame deletion of 27 amino acids and insertion of 2 novel amino acids for a net loss of 25 amino acids in a nonrepeat region (PM4).
PP4
This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; PMID:28726111).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Not Met criteria codes
PS4
This variant was identified in three unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 28726111, internal lab contributors).
PM1
Not in a glucose- or ATP-binding residue.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.